Roe Jae-Seok, Youn Hong-Duk
Department of Biochemistry and Molecular Biology, Cancer Research Institute, Interdisciplinary Program in Genetic Engineering, Seoul National University College of Medicine, Seoul, Republic of Korea.
Cell Cycle. 2006 Sep;5(18):2054-6. doi: 10.4161/cc.5.18.3247. Epub 2006 Sep 15.
The ubiquitin-mediated degradation of hypoxia-inducible factor-alpha (HIF-alpha) by a von Hippel-Lindau tumor suppressor protein (pVHL) is mechanistically responsible for controlling gene expression due to oxygen availability. Germline mutations in the VHL gene cause dysregulation of HIF and induce an autosomal dominant cancer syndrome referred to as VHL disease. However, it is unclear whether HIF accumulation caused by VHL mutations is sufficient for tumorigenesis. Recently, we found that pVHL directly associates and positively regulates the tumor suppressor p53 by inhibiting Mdm2-mediated ubiquitination, and by subsequently recruiting p53-modifying enzymes. Moreover, VHL-deleted RCC cells showed attenuated apoptosis or abnormal cell-cycle arrest upon DNA damage, but became normal when pVHL was restored. Thus, pVHL appears to play a pivotal role in tumor suppression by participating actively as a component of p53 transactivation complex during DNA damage response.
泛素介导的缺氧诱导因子-α(HIF-α)被冯·希佩尔-林道肿瘤抑制蛋白(pVHL)降解,从机制上负责因氧可用性而控制基因表达。VHL基因的种系突变导致HIF失调,并诱发一种常染色体显性癌症综合征,称为VHL病。然而,尚不清楚由VHL突变引起的HIF积累是否足以引发肿瘤发生。最近,我们发现pVHL通过抑制Mdm2介导的泛素化,随后招募p53修饰酶,直接与肿瘤抑制因子p53结合并对其进行正向调节。此外,VHL缺失的肾癌细胞在DNA损伤时凋亡减弱或细胞周期阻滞异常,但当恢复pVHL时则恢复正常。因此,pVHL似乎在肿瘤抑制中起关键作用,在DNA损伤反应期间作为p53反式激活复合物的一个组分积极参与其中。